MAG
Myelin-associated glycoprotein
Also known as: GMA, MAG_HUMAN, S-MAG, SIGLEC-4A, SIGLEC4A
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P20916
- Gene
- MAG
- Ensembl
- ENSG00000105695
- Chromosome
- 19
- Canonical length
- 626 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Equatorial segment,Perinuclear theca
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is a type I membrane protein and member of the immunoglobulin superfamily. It is thought to be involved in the process of myelination. It is a lectin that binds to sialylated glycoconjugates and mediates certain myelin-neuron cell-cell interactions. Three alternatively spliced transcripts encoding different isoforms have been described for this gene. [provided by RefSeq, Nov 2010]
Canonical amino-acid sequenceUniProt
626 residues, UniProt reviewed canonical sequence.
>P20916|MAG
1 MIFLTALPLF WIMISASRGG HWGAWMPSSI SAFEGTCVSI PCRFDFPDEL RPAVVHGVWY
61 FNSPYPKNYP PVVFKSRTQV VHESFQGRSR LLGDLGLRNC TLLLSNVSPE LGGKYYFRGD
121 LGGYNQYTFS EHSVLDIVNT PNIVVPPEVV AGTEVEVSCM VPDNCPELRP ELSWLGHEGL
181 GEPAVLGRLR EDEGTWVQVS LLHFVPTREA NGHRLGCQAS FPNTTLQFEG YASMDVKYPP
241 VIVEMNSSVE AIEGSHVSLL CGADSNPPPL LTWMRDGTVL REAVAESLLL ELEEVTPAED
301 GVYACLAENA YGQDNRTVGL SVMYAPWKPT VNGTMVAVEG ETVSILCSTQ SNPDPILTIF
361 KEKQILSTVI YESELQLELP AVSPEDDGEY WCVAENQYGQ RATAFNLSVE FAPVLLLESH
421 CAAARDTVQC LCVVKSNPEP SVAFELPSRN VTVNESEREF VYSERSGLVL TSILTLRGQA
481 QAPPRVICTA RNLYGAKSLE LPFQGAHRLM WAKIGPVGAV VAFAILIAIV CYITQTRRKK
541 NVTESPSFSA GDNPPVLFSS DFRISGAPEK YESERRLGSE RRLLGLRGEP PELDLSYSHS
601 DLGKRPTKDS YTLTEELAEY AEIRVKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MAG can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 700 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 700 nTPM
- midbrain: 270 nTPM
- hippocampal formation: 206 nTPM
- basal ganglia: 159 nTPM
- hypothalamus: 109 nTPM
- amygdala: 105 nTPM
Single-cell type
- oligodendrocytes: 466 nCPM
- epididymal efferent duct absorptive cells: 88 nCPM
- ovarian stromal cells: 77 nCPM
- fallopian secretory cells: 66 nCPM
- granulosa cells: 49 nCPM
- schwann cells: 21 nCPM
Immune cell
- plasmacytoid DC: 2.9 nTPM
- naive B-cell: 0.2 nTPM
- non-classical monocyte: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
Brain region
- white matter: 1,500 nTPM
- medulla oblongata: 994 nTPM
- basal ganglia: 776 nTPM
- pons: 714 nTPM
- midbrain: 689 nTPM
- cerebellum: 685 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MAG.
Disease | AllUniProt
Conditions MAG is implicated in, by any mechanism.
- Spastic paraplegia 75, autosomal recessive (SPG75) MIM:616680
Disease | GeneticClinVar
16 pathogenic / likely-pathogenic of 371 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Hereditary spastic paraplegia 75
- Orofacial cleft 1
Disease | ImmuneIEDB
Conditions an epitope on MAG was assayed in.
- multiple sclerosis B and T cell
Disease | AutoantibodyPubMed
Conditions in which antibodies against MAG are reported. Each links to that disease's full target list.
- Paraproteinemias 16
- Polyneuropathies 16
- Peripheral Nervous System Diseases 15
- Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 10
- Polyradiculoneuropathy 6
Showing 5 of 7 — disease pages carrying at least 10 antigens.
ReferencesPubMed · IEDB
Publications for MAG from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
52 publications
- Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy.
1994 · Ann Neurol · RCR 7.6 · 216 citations - Polyneuropathy and IgM monoclonal gammopathy: studies on the pathogenetic role of anti-myelin-associated glycoprotein antibody.
1985 · Ann Neurol · RCR 7.6 · 177 citations - Clinical correlates of elevated serum concentrations of cytokines and autoantibodies in patients with spinal cord injury.
2007 · Arch Phys Med Rehabil · RCR 5.3 · 190 citations - Rituximab in the treatment of polyneuropathy associated with anti-MAG antibodies.
2003 · Muscle Nerve · RCR 4 · 149 citations - Myelin basic protein as an encephalitogen in encephalomyelitis and polyneuritis following rabies vaccination.
1987 · N Engl J Med · RCR 4 · 127 citations
Show 20 more of 52 total
- The Role of Complement Activation in IgM M-Protein-Associated Neuropathies.
2025 · Neurol Neuroimmunol Neuroinflamm · RCR 3.8 · 10 citations - Neuropathy with anti-myelin-associated glycoprotein antibodies: update on diagnosis, pathophysiology and management.
2025 · J Neurol Neurosurg Psychiatry · RCR 3.8 · 10 citations - Mutational Profile in 75 Patients With Anti-Myelin-Associated Glycoprotein Neuropathy: Clinical and Hematologic Therapy Response and Hints on New Therapeutic Targets.
2023 · Neurol Neuroimmunol Neuroinflamm · RCR 3.3 · 23 citations - Intermittent cyclophosphamide and prednisone treatment of polyneuropathy associated with monoclonal gammopathy of undetermined significance.
1996 · Neurology · RCR 3.3 · 84 citations - Predictors of response to rituximab in patients with neuropathy and anti-myelin associated glycoprotein immunoglobulin M.
2007 · J Peripher Nerv Syst · RCR 2.7 · 90 citations - A diagnostic score for anti-myelin-associated-glycoprotein neuropathy or chronic inflammatory demyelinating polyradiculoneuropathy in patients with anti-myelin-associated-glycoprotein antibody.
2023 · Eur J Neurol · RCR 2.5 · 13 citations - Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy.
2009 · Neurology · RCR 2 · 63 citations - Can electrophysiology differentiate polyneuropathy with anti-MAG/SGPG antibodies from chronic inflammatory demyelinating polyneuropathy?
2002 · Clin Neurophysiol · RCR 1.9 · 63 citations - Clinical and laboratory features of anti-MAG neuropathy without monoclonal gammopathy.
2019 · Sci Rep · RCR 1.9 · 29 citations - Serum neurofilament light chain, contactin-1 and complement activation in anti-MAG IgM paraprotein-related peripheral neuropathy.
2022 · J Neurol · RCR 1.7 · 17 citations - Efficacy of rituximab in anti-myelin-associated glycoprotein demyelinating polyneuropathy: Clinical, hematological and neurophysiological correlations during 2 years of follow-up.
2022 · Eur J Neurol · RCR 1.6 · 14 citations - Antibody testing in neuropathy associated with anti-Myelin-Associated Glycoprotein antibodies: where we are after 40 years.
2021 · Curr Opin Neurol · RCR 1.6 · 20 citations - IgM Flare in Anti-MAG Neuropathy Post Rituximab Treatment: A Clinical Case and a Systematic Review of the Literature.
2024 · Brain Sci · RCR 1.4 · 4 citations - Confocal microscopic localization of anti-myelin-associated glycoprotein autoantibodies in a patient with peripheral neuropathy initially lacking a detectable IgM gammopathy.
1998 · Acta Neuropathol · RCR 1.4 · 46 citations - HCV-related central and peripheral nervous system demyelinating disorders.
2014 · Inflamm Allergy Drug Targets · RCR 1.4 · 35 citations - Autocrine TNF-α Increases Penetration of Myelin-Associated Glycoprotein Antibodies Across the Blood-Nerve Barrier in Anti-MAG Neuropathy.
2023 · Neurol Neuroimmunol Neuroinflamm · RCR 1.3 · 7 citations - Autopsy-proven amyotrophic lateral sclerosis, Waldenström's macroglobulinemia, and antibodies to sulfated glucuronic acid paragloboside.
1995 · Neurology · RCR 1.2 · 35 citations - Neuropathy and anti-myelin-associated glycoprotein IgM M proteins: T cell regulation of M protein secretion in vitro.
1985 · Ann Neurol · RCR 1.1 · 28 citations - Antiganglioside antibodies in polyneuropathy associated with monoclonal gammopathy.
2001 · Neurology · RCR 1.1 · 35 citations - Delayed appearance of anti-myelin-associated glycoprotein antibodies in a patient with chronic demyelinating polyneuropathy.
1993 · Ann Neurol · RCR 1.1 · 25 citations
Reference: B cellIEDB
2 publications
- High-Density Peptide Microarray Analysis of IgG Autoantibody Reactivities in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients.
2016 · Mol Cell Proteomics · RCR 2.5 · 66 citations - Multiple MAG peptides are recognized by circulating T and B lymphocytes in polyneuropathy and multiple sclerosis.
2002 · Eur J Neurol · RCR 0.5 · 28 citations
Reference: T cellIEDB
1 publication
- Autoreactive CD8+ T-cell responses to human myelin protein-derived peptides.
1994 · Proc Natl Acad Sci U S A · RCR 3 · 137 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.42
- gnomAD pLI
- 0.49
- gnomAD missense Z
- 1.13
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- axon regeneration
- cell adhesion
- cell-cell adhesion via plasma-membrane adhesion molecules
- cellular response to mechanical stimulus
- central nervous system myelin formation
- negative regulation of axon extension
- negative regulation of neuron apoptotic process
- negative regulation of neuron differentiation
- negative regulation of neuron projection development
- positive regulation of astrocyte differentiation
- positive regulation of myelination
- substantia nigra development
- transmission of nerve impulse
Molecular functions
- carbohydrate binding
- ganglioside GT1b binding
- protein homodimerization activity
- protein kinase binding
- sialic acid binding
- signaling receptor binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MAG in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MAG as an antibody target. Whether an autoantibody or antibody against MAG could matter depends on whether native MAG is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MAG is annotated at the cell surface, where native MAG is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label MAG as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...